// App-Quantinova.ai

TCT-500 : Silent Occlusion, But Not Restenosis Without Occlusion After Primary Percutaneous Intervention Strongly Predicts Both Deterioration Of Cardiac Function And Future Clinical Events

Researchers

Presenter

  • Shinichiro Yamada

Principal Investigators

  • Hiroyuki Shibata

  • Yoshinori Yasaka

  • Akira Shimane

  • Seiichi Kobayashi

  • Tomofumi Takaya

  • Kiminobu Yokoi

  • Naoki Miyoshi

  • Shogo Oishi

  • Takayoshi Toba

  • Hachidai Takahashi

Medical Centers

  • Himeji Cardiovascular Center, Himeji, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Congestive heart failure

  • Acute Coronary Syndromes

  • Coronary Artery Disease

  • Restenosis

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • technetium tc 99m tetrofosmin Injection

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved